β-Caryophyllene (BCP) ameliorates MPP+ induced cytotoxicity.

Key Findings:  MPP+ (1-methyl-4-phenylpyridinium) has been reported to be a major neurotoxin causing neurotoxic insults on dopaminergic neurons in humans. The authors conclude that BCP might act as a promising therapeutic agent against MPP+ toxicity in neuronal cells.

Type of Study:  Laboratory Study

Study Result:  Positive

Cannabinoids Studied:  Not Applicable

Phytocannabinoid Source:  Not Applicable

Form of Administration:  Not Applicable

Terpenes Studied:  ß-Caryophyllene

Receptors Studied:  CB2

Study Location(s):  China

Year of Pub:  2018

Link to study